Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T14:38:19.783Z.
Calculation as of: 2026-10-06T14:38:19.783Z.
Quote observation: 2026-10-06T14:34:53.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 04c3f12431ab3e8d6f15e27a04b3f35a1ccc42ae6fada6e5bc04b9c12e20bb1c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$16.58M
Price/FCF Ratio
N/A
TTM Avg
43.53
3Y Avg
55.71
5Y Avg
97.87
Market Cap
$15.60M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.42M
Price/FCF Ratio
N/A
TTM Avg
82.38
3Y Avg
82.38
5Y Avg
82.38
Market Cap
$18.86M
Price/FCF Ratio
N/A
TTM Avg
126.35
3Y Avg
822.33
5Y Avg
822.33
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | $17.07M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.34M | N/A | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.58M | N/A | 43.53 | 55.71 | 97.87 |
| BioCardia, Inc. (BCDA)vs › | $15.92M | N/A | 121.92 | 75.43 | 64.77 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.60M | N/A | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | N/A | 82.38 | 82.38 | 82.38 |
| NextCure, Inc. (NXTC)vs › | $18.82M | N/A | 278.20 | 278.20 | 278.20 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | N/A | 126.35 | 822.33 | 822.33 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
